Table 3 Characteristics of follow-up time
Number patients = 157 | ||
|---|---|---|
Duration of follow-up, symptom onset to end of study period - n (%) | ||
Less than one year | 20 | (12.7) |
Greater than or equal to one year; less than two years | 56 | (35.7) |
Two years or more | 80 | (51.0) |
Duration of observation during two year resource collection period - n (%) | ||
Duration of observation | ||
Less than one year | 20 | (12.7) |
Greater than or equal to one year; less than two years | 62 | (39.5) |
Exactly two years | 75 | (47.8) |
Reasons for truncated observation period | ||
Symptom onset after start of collection period | 75 | (47.8) |
Died prior to end of collection perioda | 14 | (8.9) |
Duration of follow-up, in years – mean (standard deviation) | ||
Time from symptom onset to initial diagnosis of NTMLD | 0.4 | (0.6) |
Time from initial diagnosis to end of study period or death | 2.1 | (1.7) |
Time from initial diagnosis to treatment start | 0.3 | (0.7) |
Observation time during prior 24-month study period | 1.7 | (0.4) |
Duration of follow-up, in years – median (range) | ||
Time from symptom onset to initial diagnosis of NTMLD | 0.3 | (0–5) |
Time from initial diagnosis to end of study period or death | 1.6 | (0–13) |
Time from initial diagnosis to treatment start | 0.1 | (0–6) |
Observation time during prior 24-month study period | 1.9 | (0–2) |